Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum biOasis Technologies Ord Shs BIOAF


Primary Symbol: V.BTI.H

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in... see more

TSXV:BTI.H - Post Discussion

biOasis Technologies Ord Shs > Midatech Share Price Is Dropping
View:
Post by Boomskid on Feb 24, 2023 2:13pm

Midatech Share Price Is Dropping

Midatech's share price has been dropping from 76.5¢ on February 9th, the day that Midatech announced its new financing at an initial proice of 58¢ per unit. As I write this, the Midatech share price is down 33% to 50.8¢.

The financing could be priced as low as 30¢ per unit dependent on share price. Dependent on certain shareholder approvals, certain aspects of the financing could be priced as low as 10¢ per unit. This would essentially wipe out current Midatech shareholders who would then have ~5% ownership of Midatech.

If there is a Bioasis deal coming with those almost worthless Midatech shares, then current Bioasis shareholders could end up with 2% or 3% of the resulting company, with no guarantee that the resulting company will retain much of any ownership of xB3.

By any definition, this would be a wiping out of Bioasis shareholder ownership of xB3. 

Why is the Midatech share price dropping? Is it the market and the S&P Biotech EGF or might there be motive for others to do it?

jd
Comment by prophetoffactz on Feb 24, 2023 2:29pm
"Midatech's share price has been dropping from 76.5¢ on February 9th, the day that Midatech announced its new financing at an initial proice of 58¢ per unit. As I write this, the Midatech share price is down 33% to 50.8¢." The S&P Biotech ETF began dropping around the same time. Since Feb 2 it is down about 11.2%. That's a big drop for an index with advanced ...more  
Comment by Boomskid on Feb 24, 2023 3:01pm
Bwah hahahaha!  poof can't let it go. He still says, "The S&P Biotech ETF began dropping around the same time." Worse, he's still making excuses for Rathjen. We all know he doesn't believe that the S&P Biotech market caused today's share price of 1.5¢. So what is poof's motive for pumping Rathjen's "work" with Bioais? The ...more  
Comment by prophetoffactz on Feb 24, 2023 3:10pm
"We all know he doesn't believe that the S&P Biotech market caused today's share price of 1.5¢." If BTI traded below cash, and it has none, given all the debt that it also has where would it be trading? It's a miracle it isn't trading at negative cents.
Comment by Boomskid on Feb 24, 2023 3:38pm
poof says that it's a wonder that BTI isn't "trading at negative cents." If you have any shares, poof, I'll take them off your hands if you pay me 1.5¢ for each one. jd
Comment by ROSIE2023 on Feb 24, 2023 3:21pm
I don't believe based on what has been stated , the midatech options are dead in the water  they don't have the authorization to pursue a deal without shareholder approval  am I correct ?